Overview
On January 15, 2025, Citeline's Pink Sheet quoted Steptoe senior counsel, Elisabethann Wright in an article "EU Pharma Reform & Reducing Reliance On Asian Imports: What To Expect in 2025." The article discusses the European Commission's plan to propose a Critical Medicines Act to address the EU's dependence on imports of active pharmaceutical ingredients and finished medicines from Asia. This proposal is expected to be formally debated by the Council of the EU in June, 2025. The Council will also review the EU's pharmaceutical reform package, which has been under negotiation for several years. The new Polish presidency of the Council has committed to advancing these discussions, though it remains uncertain whether these issues will be top priorities.
In the article, Elisabethann Wright said: "The question remains as to whether either the pharmaceutical reform package or the proposed Critical Medicines Act will be prioritized by the Polish Presidency." She adds that while there may be space for debate on critical medicines, significant progress may be limited.
Read more at Citeline (subscription required).
